Cizzle Biotechnology Overview

  • Founded
  • 2006
Founded
  • Status
  • Public
  • Employees
  • 7
Employees
  • Stock Symbol
  • CIZ
Stock Symbol
  • Investments
  • 1

Cizzle Biotechnology General Information

Description

Provider of therapeutic services designed to develop diagnostic products in partnership with the biotech and pharma industries. The company's services intends to develop drugs for the detection and treatment of lung cancer, enabling physicians to detect lung cancer at an early stage, when there is maximum chance of getting cured.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
LON
Primary Office
  • 6th Floor
  • 60 Gracechurch Street
  • London EC3V 0HR
  • England, United Kingdom

Cizzle Biotechnology Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cizzle Biotechnology Financials Summary

In Thousands,
USD
TTM 31-Dec-2019 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
Revenue 32 32 33 0
EBITDA (35) (186)
Total Assets 22 22 31 58
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cizzle Biotechnology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cizzle Biotechnology‘s full profile, request access.

Request a free trial

Cizzle Biotechnology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Cizzle Biotechnology‘s full profile, request access.

Request a free trial

Cizzle Biotechnology Executive Team (4)

Name Title Board Seat Contact Info
Dawn Coverley Ph.D Founder & Chief Scientific Officer
You’re viewing 1 of 4 executive team members. Get the full list »

Cizzle Biotechnology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cizzle Biotechnology Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cizzle Biotechnology‘s full profile, request access.

Request a free trial

Cizzle Biotechnology Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000000000000 26-Apr-2021 000000000000000000 Special Purpose Acquisition Company (SPAC) 0000 00000000 00.0
To view Cizzle Biotechnology’s complete acquisitions history, request access »